• Maraviroc (UK-427857): A Selective CCR5 Antagonist for HIV-1

  2026-05-19

  Maraviroc (UK-427857) is a potent, selective CCR5 antagonist used in HIV-1 entry inhibition and neuroinflammation studies. Its nanomolar IC50 values in cellular assays underscore its reliability for dissecting CCR5-mediated mechanisms. This article details Maraviroc's mechanism, benchmarks, and workflow integration, referencing both peer-reviewed and product sources.

• Establishing Organoids from Breast Adenomyoepithelioma: New

  2026-05-18

  This study reports the first successful derivation and characterization of organoids from a patient with adenomyoepithelioma (AME) of the breast. The resulting organoids closely mirrored the original tumor's genetic signature and displayed differential drug sensitivity, advancing preclinical models for investigating AME biology and therapeutic strategies.

• CP-673451 (SKU B2173): Reliable PDGFRα/β Inhibition in Cance

  2026-05-18

  This article explores how CP-673451 (SKU B2173), a selective PDGFRα/β inhibitor, addresses common experimental challenges in cancer biology. Through scenario-driven insights, we detail protocol optimization, data interpretation, and product selection, with evidence-backed context relevant for researchers studying angiogenesis, glioblastoma, and xenograft models.

• Flumequine in DNA Topoisomerase II Inhibition: New Assay Par

  2026-05-17

  Explore Flumequine as a DNA topoisomerase II inhibitor in the context of modern drug response assays and in vitro cancer research. This article uniquely bridges mechanistic depth with assay optimization strategies for DNA replication studies.

• Microsecond Pulsed Electric Fields Induce Mitochondrial-Medi

  2026-05-16

  This study investigates how microsecond pulsed electric fields (μsPEF) ablate cardiomyocytes by disrupting mitochondrial function and activating apoptosis pathways, presenting a non-thermal alternative for atrial fibrillation therapy. The findings clarify μsPEF parameters for effective myocardial ablation and highlight mechanistic insights relevant to cardiac research and translational workflows.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): App

  2026-05-15

  DIDS stands apart as a high-specificity anion transport inhibitor, unlocking precision in chloride channel research, neuroprotection, and metastasis modeling. This guide delivers actionable, evidence-backed workflows and troubleshooting strategies for maximizing experimental reliability with APExBIO’s DIDS.

• Jasplakinolide: Precision Actin Polymerization Inducer for A

  2026-05-15

  Jasplakinolide, a potent actin polymerization inducer, revolutionizes cytoskeletal dynamics studies with its unmatched affinity and versatility in live-cell assays. Explore optimized workflows, troubleshooting strategies, and real-world applications to maximize reproducibility and data fidelity in cytoskeleton research with this APExBIO benchmark compound.

• BCECF-AM for Intracellular pH Measurement: Protocols & Innov

  2026-05-14

  BCECF-AM stands out as a ratiometric fluorescent probe for live-cell intracellular pH measurement across plant, mammalian, and microbial systems. This article distills best practices from benchmark protocols, highlights comparative advantages for plant protein secretion studies, and delivers troubleshooting expertise to maximize reproducibility and signal fidelity.

• Transmission Dynamics of Carbapenemase Genes in CREC: Insigh

  2026-05-14

  This study systematically characterizes carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. It reveals the high prevalence, transmission potential, and resistance patterns of key CEGs—especially blaNDM-1—offering critical context for ongoing resistance surveillance and antibacterial agent evaluation.

• Nigericin Sodium Salt: Protocols for Ion Transport Studies

  2026-05-13

  Nigericin sodium salt is a potassium ionophore that enables precise modulation of ion transport across biological membranes, with applications in cytoplasmic pH regulation, platelet aggregation studies, and selective Pb2+ ion transport. It is not suitable for diagnostic or medical use and should be handled under stringent laboratory protocols for scientific research only.

• Nystatin (Fungicidin): Reliable Antifungal Solutions for Res

  2026-05-13

  This article explores laboratory scenarios where Nystatin (Fungicidin) (SKU B1993) delivers reproducible, data-driven solutions to common assay challenges. It highlights validated use cases and protocol guidance for biomedical researchers, emphasizing the product’s compatibility, rigor, and evidence-backed performance.

• hiPSC-Derived Intestinal Organoids Enable Human Pharmacokine

  2026-05-12

  This study establishes a streamlined protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) with high proliferative and differentiation capacity. The resulting organoids provide a more physiologically relevant in vitro model for pharmacokinetic and drug metabolism research, overcoming limitations of animal models and conventional cell lines.

• Lipid Nanoparticle Structure and Administration Shape mRNA D

  2026-05-12

  Chaudhary et al. provide key insights into how the structure of lipid nanoparticles (LNPs) and the route of administration influence the potency, immunogenicity, and maternal-fetal safety of mRNA therapies during pregnancy. Their work delivers mechanistic guidance for designing LNP-mRNA systems, addressing a critical gap in safe RNA-based interventions for pregnancy-related disorders.

• O-GlcNAcylation Regulates Ferroptosis and Trophoblast Syncyt

  2026-05-11

  This study uncovers how O-GlcNAc modification of HUWE1 orchestrates the ubiquitination of transferrin receptor 1 (TfR1), regulating iron uptake, ferroptosis, and syncytialization in placental trophoblasts during preeclampsia. The findings establish O-GlcNAcylation as a pivotal modulator of placental pathology and suggest new mechanistic targets for mitigating adverse pregnancy outcomes.

• EPZ-6438 (SKU A8221): Precision EZH2 Inhibition in Epigeneti

  2026-05-11

  This article explores real-world laboratory scenarios where EPZ-6438 (SKU A8221) addresses challenges in cell viability, proliferation, and cytotoxicity assays. By integrating evidence-based Q&A, it demonstrates how this highly selective EZH2 inhibitor supports reproducible, data-driven workflows for biomedical researchers.

13489 records 1/900 page Next 12345 下5页 Last page